Diagnostics is one of the last great bottlenecks in healthcare. Not because we lack scanners or skilled clinicians, but because the system around them has barely evolved.
Manentia AI, a young Gandhinagar-based startup, is rebuilding this system from the ground up.
It is building a complete diagnostic infrastructure—a full-stack platform that makes imaging faster, workflows smoother, and clinical decisions sharper.
Not a tool. Not a feature. Not another algorithm. A complete engine for modern diagnostics.
Let’s learn more about it!
What is Manentia AI?
Manentia AI is a medical imaging startup that uses advanced AI and computer vision to make high-quality diagnostics faster, more accurate, and easier for hospitals and clinics to use.
Instead of offering one-off tools, it provides a unified platform that supports radiologists, technicians, and diagnostic centers from start to finish.
What it does: Rebuilding the diagnostic workflow
Manentia’s platform tackles diagnostic overload by focusing on high-volume thoracic imaging (chest imaging). Its core AI engines bring precision, speed, and clinical clarity to everyday radiology.
mXR – Chest X-rays with real diagnostic intelligence
mXR doesn’t just flag an abnormality; it precisely identifies what it might be.
It detects and localizes14 different chest anomalies, giving radiologists structured insights that reduce uncertainty and speed up reads.
mCT – Deep learning for complex CT scans
When cases get more complex, mCT steps in. This deep learning system specializes in detecting and characterizing nodular mass cavities. It offers detailed insights clinicians need when dealing with high-stakes cases.
Manentia backs its technology with real-world proof. Their AI models and algorithms are trained in a massive dataset of over 1.5 million clinical images to ensure they learn from diverse, real-life cases.
The startup also claims to deliver ~97% accuracy and reduce reporting turnaround times for radiology and CT scans by 91%, allowing patients to receive critical results faster.
Full-stack integration: Manentia’s biggest differentiator
What truly sets Manentia apart is its end-to-end design, moving far beyond simple image analysis.
It powers the entire diagnostic ecosystem: integrating AI with PACS storage, workflow automation, teleradiology, and operations management.
This holistic approach ensures seamless adoption, creates incredible workflow cohesion, and delivers superior value. This is why it is already trusted by over 300 diagnostic centers worldwide.
The integrated suite includes:
- mPACS: The secure, cloud-native engine for medical imaging. It handles fast DICOM storage and retrieval, connects seamlessly with imaging equipment, and enables easy sharing across multiple sites, providing the essential IT backbone for modern radiology.
- mDX (Workflow Management): This is the command center for daily operations. It streamlines all the non-clinical tasks—from tracking referrals and managing report workflows to calculating commissions—freeing up staff to focus on what matters most.
- mTR (Teleradiology): This module breaks down geographical barriers. It provides instant, on-demand access to a network of certified radiologists, empowering centers to extend their specialist services to remote clinics and areas without in-house expertise.
The result of this seamless integration is a dramatic leap in efficiency. Diagnostic centers using the platform report a 40% faster report turnaround time and the potential to double their patient capacity.
“Manentia AI distinguishes itself through the accuracy, user experience, and seamless integration options offered by its technology.” – Anuj Chandalia, CEO, Manentia AI.
About Manentia AI: Corporate trajectory, financial context, and global reach
Manentia AI was launched in 2020 by Anuj Chandalia and Jitendra Singh Virk. A team bringing together engineering, product, and clinical insight.
Their shared belief that diagnostics doesn’t need incremental fixes but a complete workflow reinvention led to where Manentia stands today.
As a seed-stage company, it has demonstrated remarkable capital efficiency, building its advanced platform with a lean $173K in funding to achieve a $3.43 Mn valuation.
The company’s reach is already global, serving clients in the healthcare and radiology sectors across India, Africa, and the UK. Its growth is strategic, fueled by initiatives such as the UK India Health Tech Bootcamp and clinical partnerships to co-develop and validate its AI models as it expands into new markets, such as Southeast Asia.
In a competitive field with giants like Median and Lunit, Manentia AI’s distinct advantage is its integrated, full-stack approach—controlling the entire diagnostic workflow from the image up.
Advanced R&D powering commercial impact
Under the hood, Manentia invests heavily in foundational research, often published in top academic journals. Recent key research includes highly accurate methods for:
- Segmentation and classification of lung nodules in CT scans
- Automated lung isolation to improve scan precision
This research-first approach ensures that every commercial product is backed by best-in-class science.
Expanding into new frontiers
Looking beyond chest imaging, the company is already deploying its AI expertise to solve other complex challenges:
- Predicting surgical risk: An AI model that analyzes patient data to forecast post-surgery complications, potentially preventing unnecessary hospital stays.
- Mobile eye screening: A practical solution for diagnosing diabetic retinopathy and macular degeneration using images taken with smartphone attachments, making specialized eye care accessible in remote or developing regions.
- Smarter emergency dispatch: An intelligent system that automates ambulance dispatch by triaging emergency calls, deciding on the required resources, and providing all critical data to optimize response times and save lives.
Clinical traction and global recognition
This rapid innovation has been matched by impressive clinical adoption. The platform has earned the trust of over 10,000 healthcare professionals and is in direct use at more than 300 diagnostic centers globally.
Manentia AI has also been chosen by the Office of Economic Development Düsseldorf asone of eight international startups to showcase at the prestigious MEDICA 2025 Start-up Park.
Wrapping up
Manentia AI is solving the diagnostic equation end-to-end by pairing high-accuracy AI with the infrastructure that modern radiology desperately needs.
This combination of technical depth, full-stack integration, and clinical impact positions the startup not just as a rising player but as a potential future leader in global diagnostic intelligence.
-By Alkama Sohail and the AHT Team
